Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Fulcrum Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −9 vs. Q3 2024
- Shares held
- 51.7M
- −2.97M (−5.4%) vs. Q3 2024
- Total value
- $243.4M
- +$47.8M (+24.4%) vs. Q3 2024
- New holders
- 24
- 33 more added
- Sold out
- 33
- 40 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,975 | $18.7K | 0.00% | −24,145−85.9% | Reduced |
| Skopos Labs, Inc. | 3,936 | $18.5K | 0.01% | +3,936 | New |
| IFP Advisors, Inc | 2,294 | $11.0K | 0.00% | +1,393+154.6% | Added |
| Amalgamated Bank | 2,147 | $10.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 1,667 | $7.83K | 0.00% | +328+24.5% | Added |
| Sterling Capital Management LLC | 1,239 | $5.82K | 0.00% | +1,099+785.0% | Added |
| Steward Partners Investment Advisory, LLC | 790 | $3.71K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 758 | $3.56K | 0.00% | +758 | New |
| National Bank of Canada | 460 | $2.16K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 314 | $1.48K | 0.00% | +267+568.1% | Added |
| Caitong International Asset Management Co., Ltd | 145 | $682 | 0.00% | +145 | New |
| C M Bidwell & Associates Ltd | 117 | $550 | 0.00% | +117 | New |
| HighMark Wealth Management LLC | 100 | $470 | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 95 | $447 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 26 | $122 | 0.00% | +26 | New |
| Larson Financial Group LLC | 15 | $71 | 0.00% | +15 | New |
| The PNC Financial Services Group, Inc. | 5 | $24 | 0.00% | +5 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3 | $14 | 0.00% | −2,472−99.9% | Reduced |
| CWM, LLC | 10 | $0 | 0.00% | +5+100.0% | Added |
| TRV GP IV, LLC | 0 | $0 | 0.00% | −2,343,154−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −1,069,158−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −340,495−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −307,414−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −202,030−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −146,238−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −123,009−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −97,891−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −88,130−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −76,577−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −71,103−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −48,324−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −34,846−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −32,368−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −25,401−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −25,234−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −25,025−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −17,142−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −16,554−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −12,002−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −11,813−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,374−100.0% | Sold out |
| Perritt Capital Management Inc | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −4,392−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −2,257−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −1,165−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −74−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| Mass General Brigham, Inc | – | – | – | – | Not filed |
| AJOVista, LLC | – | – | – | – | Not filed |